Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Shares of Lobo Technologies Ltd (NASDAQ: LOBO ) rose sharply in pre-market trading after the company reported a year-over-year increase in H1 financial results. Lobo EV Technologies posted a H1 loss of 7 cents per share, versus a year-ago loss of 28 cents per share. The company’s sales rose to $14.587 million from $12.091 million. Lobo Technologies shares jumped 32.4% to $0.70 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Greenland Energy Co (NASDAQ: GLND ) gained 138.3% to $2.86 in pre-market trading. Black Titan Corp (NASDAQ: BTTC ) rose 95.2% to $0.71 in pre-market trading after dipping around 4% on Friday. Greenland Mines Ltd (NASDAQ: GRML ) rose 73.3% to $4.94 in pre-market trading after falling over 4% on Friday. Critical Metals Corp (NASDAQ: CRML ) gained 30.7% to $8.79 in pre-market trading after falling 2% on Friday. Cue Biopharma Inc (NASDAQ: CUE ) rose 29.8% to $48.11 in pre-market trading after announcing positive topline results from CUE-221 Phase 2 study in chronic spontaneous urticaria. DDC Enterprise Ltd (NYSE: DDC ) rose 20% to $0.29 in pre-market trading after surging around 3% on Friday. Avalanche Treasury Corp ( NASDAQ: A
Shares of Lobo Technologies Ltd (NASDAQ: LOBO ) rose sharply in pre-market trading after the company reported a year-over-year increase in H1 financial results. Lobo EV Technologies posted a H1 loss of 7 cents per share, versus a year-ago loss of 28 cents per share. 091 million. 70 in pre-market trading Here are some other stocks moving in pre-market trading.
86 in pre-market trading. 71 in pre-market trading after dipping around 4% on Friday. 94 in pre-market trading after falling over 4% on Friday. 79 in pre-market trading after falling 2% on Friday.
11 in pre-market trading after announcing positive topline results from CUE-221 Phase 2 study in chronic spontaneous urticaria. 29 in pre-market trading after surging around 3% on Friday. 26 in pre-market trading after jumping around 23% on Friday. 99 in pre-market trading after falling over 6% on Friday.
81 in pre-market trading. 47 in pre-market trading after jumping 68% on Friday. 65 in pre-market trading. 1 million common shares by selling stockholders.
21 in pre-market trading after jumping 143% on Friday. 67 in pre-market trading. Delixy recently announced a 1-for-5 reverse stock split. 45 in pre-market trading after jumping 92% on Friday.
00 in pre-market trading after gaining 4% on Friday. 96 in pre-market trading. 45 in pre-market trading. 60 in pre-market trading.
Telix Pharmaceuticals signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE. 67 in pre-market trading. Photo via Shutterstock